| Q33952157 | A prospective study of diurnal cortisol and cognitive function in community-dwelling elderly people. |
| Q43853696 | Aberrant Brain Activation During a Working Memory Task in Psychotic Major Depression |
| Q36442053 | Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis |
| Q36821112 | Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression |
| Q38220580 | Anna-Monika Award Lecture, DGPPN Kongress, 2013: the role of the hypothalamic-pituitary-adrenal (HPA) axis in the pathogenesis of psychotic major depression |
| Q48148070 | Association between cortisol awakening response and memory function in major depression |
| Q36897249 | Atypical evening cortisol profile induces visual recognition memory deficit in healthy human subjects |
| Q21651040 | Chronic Stress-induced Hippocampal Vulnerability: The Glucocorticoid Vulnerability Hypothesis |
| Q37571623 | Chronic stress- and sex-specific neuromorphological and functional changes in limbic structures |
| Q48612014 | Cognition and HPA axis reactivity in mildly to moderately depressed outpatients: a case-control study |
| Q57808795 | Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective |
| Q48081670 | Cognitive functioning and cortisol profiles in first episode major depression |
| Q38440444 | Cognitive functioning and cortisol suppression in recurrent major depression |
| Q33566109 | Cognitive impairment in affective psychoses: a meta-analysis |
| Q51962925 | Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis. |
| Q42034176 | Cognitive impairments in major depression and bipolar disorders |
| Q47659984 | Corticotropin-releasing factor 1 receptor haplotype and cognitive features of major depression |
| Q36840470 | Current issues in the classification of psychotic major depression |
| Q35743450 | Depression and stress: is there an endophenotype? |
| Q42426187 | Differential MR/GR activation in mice results in emotional states beneficial or impairing for cognition |
| Q99556572 | Double-blind, placebo-controlled trial of mifepristone on cognition and depression in alcohol dependence |
| Q47644943 | Effects of an exercise program on the physiological, biological and psychological profiles in patients with mood disorders: a pilot study. |
| Q55417835 | Evaluation of Autonomic Nervous System, Saliva Cortisol Levels, and Cognitive Function in Major Depressive Disorder Patients. |
| Q89547080 | Examining HPA-axis functioning as a mediator of the relationship between depression and cognition across the adult lifespan |
| Q34713948 | Experimental evidence for a motivational origin of cognitive impairment in major depression |
| Q37818507 | HPA axis alterations in mental disorders: impact on memory and its relevance for therapeutic interventions |
| Q35117328 | HPA axis genetic variation, cortisol and psychosis in major depression |
| Q37647371 | HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition |
| Q37070792 | Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression |
| Q37764494 | Impact of the hypothalamic-pituitary-adrenal/gonadal axes on trajectory of age-related cognitive decline |
| Q36870916 | Insular cortex abnormalities in psychotic major depression: relationship to gender and psychotic symptoms |
| Q36218444 | Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review |
| Q35647316 | Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals |
| Q30488649 | Neurocognitive allied phenotypes for schizophrenia and bipolar disorder |
| Q28741314 | Neurodegenerative properties of chronic pain: cognitive decline in patients with chronic pancreatitis |
| Q28220405 | Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression |
| Q37496193 | Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications |
| Q38771510 | Stress and Depression: a Crucial Role of the Mineralocorticoid Receptor. |
| Q92318480 | Stress effects on cognitive function in patients with major depressive disorder: Does childhood trauma play a role? |
| Q37581144 | The Cognitive Functions in Adults with Chronic Pain: A Comparative Study |
| Q36787614 | The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. |
| Q45290829 | The relationship between cortisol and verbal memory in the early stages of Huntington's disease |
| Q35844284 | The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models |
| Q36712991 | Therapy Insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression? |
| Q46445549 | White matter correlates of impaired attention control in major depressive disorder and healthy volunteers. |
| Q37455456 | kappa-Opioid receptor signaling and brain reward function |